ARCHIVED - Cervical Cancer Screening in Canada: 1998 Surveillance Report

References

Footnote 1

Cancer Division, Health Canada, 2001.

Footnote 2

National Cancer Institute of Canada. Canadian cancer statistics 1995. Toronto, Canada, 1995.

Footnote 3

The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 Bethesda Workshop. Am J Surg Pathol 1992;16(9):914-6.

Return to footnote3 referrer

Footnote 4

Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 1973;33(6):1353-67.

Return to footnote4 referrer

Footnote 5

Harris RW, Brinton LA, Cowdell RH, Skegg DC, Smith PG, Vessey MP, et al. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer 1980;42(3):359-69.

Return to footnote5 referrer

Footnote 6

Brinton LA, Reeves WC, Brenes MM, Herrero R, Gaitan E, Tenorio F, et al. The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer 1989;44(2):199-203.

Return to footnote6 referrer

Footnote 7

Buckley JD, Harris RW, Doll R, Vessey MP, Williams PT. Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet 1981;2(8254):1010-5.

Return to footnote7 referrer

Footnote 8

Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85(12):958-64.

Return to footnote8 referrer

Footnote 9

Kjaer SK, Nielsen NH. Cancer of the female genital tract in Circumpolar Inuit. Acta Oncol 1996;35(5):581-7.

Return to footnote9 referrer

Footnote 10

Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. Can Med Assoc J 2000;163(5):503-8.

Return to footnote10 referrer

Footnote 11

Olesen F. A case-control study of cervical cytology before diagnosis of cervical cancer in Denmark. Int J Epidemiol 1988;17(3):501-8.

Return to footnote11 referrer

Footnote 12

La Vecchia C, Franceschi S, Decarli A, Fasoli M, Gentile A, Tognoni G. "Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet 1984;2(8406):779-82.

Return to footnote12 referrer

Footnote 13

Winkelstein W Jr. Smoking and cervical cancer - current status: a review. Am J Epidemiol 1990;131(6):945-57; discussion 958-60.

Return to footnote13 referrer

Footnote 14

Schiffman MH, Haley NJ, Felton JS, Andrews AW, Kaslow RA, Lancaster WD, et al. Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res 1987;47(14):3886-8.

Return to footnote14 referrer

Footnote 15

Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995;76(10 Suppl):1888-901.

Return to footnote15 referrer

Footnote 16

Brinton LA. Oral contraceptives and cervical neoplasia. Contraception 1991;43(6):581-95.

Return to footnote16 referrer

Footnote 17

Schiffman MH, Brinton LA, Devessa SS, Fraumeni JF Jr. Cervical cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 1996;1090-116.

Return to footnote17 referrer

Footnote 18

Franco EL. Epidemiology of uterine cancers. In: Meisels A, Morin C, editors. Cytopathology of the uterus. 2nd ed. Chicago: American Society of Clinical Pathologists; 1997;301-24.

Return to footnote18 referrer

Footnote 19

National Cancer Institute of Canada. Canadian cancer statistics. Toronto, Canada, 2002.

Return to footnote19 referrer

Footnote 20

Young TK. Emergence of chronic disease. In: The health of native Americans. New York: Oxford University Press; 1994:100-01.

Return to footnote20 referrer

Footnote 21

Nielsen NH, Storm HH, Gaudette LA, Lanier AP. Cancer in circumpolar Inuit 1969-1988. A summary. Acta Oncol 1996;35(5):621-8.

Return to footnote21 referrer

Footnote 22

National Cancer Institute of Canada. Canadian cancer statistics. Toronto, Canada, 1991.

Return to footnote22 referrer

Footnote 23

Young TK, Kliewer E, Blanchard J, Mayer T. Monitoring disease burden and preventive behavior with data linkage: cervical cancer among aboriginal people in Manitoba, Canada. Am J Public Health 2000;90(9):1466-8.

Return to footnote23 referrer

Footnote 24

Chaudhry M. Cancer incidence, mortality and survival among status Indians in Ontario (dissertation). Toronto: University of Toronto, 1998.

Return to footnote24 referrer

Footnote 25

Band PR, Gallagher RP, Threlfall WJ, Hislop TG, Deschamps M, Smith J. Rate of death from cervical cancer among native Indian women in British Columbia. Can Med Assoc J 1992;147(12):1802-4.

Return to footnote25 referrer

Footnote 26

Hislop TG, Deschamps M, Band PR, Smith JM, Clarke HF. Participation in the British Columbia Cervical Cytology Screening Programme by Native Indian women. Can J Public Health 1992;83(5):344-345.

Return to footnote26 referrer

Footnote 27

Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000;86(3):429-435

Return to footnote27 referrer

Footnote 28

Task Force on Cervical Cancer Screening Programs. Cervical cancer screening programs (The Walton Report). Can Med Assoc J 1976;114:1003-33.

Return to footnote28 referrer

Footnote 29

Kassirer E. Impact of the Walton report on cervical cancer screening programs in Canada. Can Med Assoc J 1980;122(4):417-23.

Return to footnote29 referrer

Footnote 30

Walton RJ, Allen, HH, Anderson, GH, et al. Cervical cancer screening programs: summary of the 1982 Canadian Task Force Report. Can Med Assoc J 1982;127:581-9.

Return to footnote30 referrer

Footnote 31

Miller AB, Anderson G, Brisson J, Laidlaw J, Le Pitre N, Malcolmson P, et al. Report of a National Workshop on Screening for Cancer of the Cervix. Can Med Assoc J 1991;145(10):1301-25.

Return to footnote31 referrer

Footnote 32

Morrison BJ. Screening for cervical cancer. In: Canadian Task Force on the Periodic Health Examination. Canadian guide to clinical preventive health care. Ottawa: Health Canada, 1994:870-881.

Return to footnote32 referrer

Footnote 33

Bowman JA, Sanson-Fisher R, Redman S. The accuracy of self-reported Pap smear utilisation. Soc Sci Med 1997;44(7):969-76.

Return to footnote33 referrer

Footnote 34

Lee J, Parsons GF, Gentleman JF. Falling short of Pap test guidelines. Health Reports (Statistics Canada cat. no. 82-003-XPB) 1998;10(1):9-19.

Return to footnote34 referrer

Footnote 35

Patnick J (ed). NHS cervical screening programme review. Sheffield, United Kingdom, 1999.

Return to footnote35 referrer

Footnote 36

Australian Institute of Health and Welfare (AIHW). Cervical Screening in Australia 1997-1998. AIHW Cat No. 9. Canberra: Australian Institute of Health and Welfare (Cancer Series number 14), 2000.

Return to footnote36 referrer

Footnote 37

Liu S, Semenciw R, Mao Y. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. Can Med Assoc J 2001;164(8):1151-2.

Return to footnote37 referrer

Footnote 38

Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, et al. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998;75(4):536-545.

Return to footnote38 referrer

Footnote 39

Boon ME, de Graaff Guilloud JC, Kok LP, Olthof PM, van Erp EJ. Efficacy of screening for cervical squamous and adenocarcinoma. The Dutch experience. Cancer 1987;59(4):862-6.

Return to footnote39 referrer

Footnote 40

Mitchell H, Medley G, Gordon I, Giles G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit. Br J Cancer 1995;71(4):894-7.

Return to footnote40 referrer

Footnote 41

Buntinx F, Brouwers M. Relation between sampling device and detection of abnormality in cervical smears: a meta-analysis of randomised and quasi-randomised studies. BMJ 1996;313:1285-90.

Return to footnote41 referrer

Footnote 42

Miller AB. Editorial: Failures of cervical cancer screening. Am J Public Health 1995;85:761-762.

Return to footnote42 referrer

Footnote 43

Carmichael JA, Jeffrey JF, Steele HD, Ohlke ID. The cytologic history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol 1984;148(5):685-90.

Return to footnote43 referrer

Footnote 44

Benoit AG, Krepart GV, Lotocki RJ. Results of prior cytologic screening in patients with a diagnosis of Stage I carcinoma of the cervix. Am J Obstet Gynecol 1984;148(5):690-4.

Return to footnote44 referrer

Footnote 45

Sweet L, Tesch M, Dryer D, McAleer. A review of the cervical cytology screening history of PEI women diagnosed with carcinoma of the cervix: 1981-1986. Chron Dis Can 1991;12:1-3.

Return to footnote45 referrer

Footnote 46

Anderson GH, Benedet JL, Le Riche JC, Matisic JP, Thompson JE. Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1985-1988. Obstet Gynecol 1992;80(1):1-4.

Return to footnote46 referrer

Footnote 47

Stuart GC, McGregor SE, Duggan MA, Nation JG. Review of the screening history of Alberta women with invasive cervical cancer. Can Med Assoc J 1997;157(5):513-9.

Return to footnote47 referrer

Footnote 48

Shaw P, Osboren RJ, Nishri D, Cherry N, Clark EA. Review of the cervical screening history of Ontario women with cancer of the cervix. Presented at the Society of Canadian Colposcopists meeting, Victoria, BC, June 27th 1998.

Return to footnote48 referrer

Footnote 49

Prince Edward Island Pap Screening Program.

Return to footnote49 referrer

Footnote 50

British Columbia Cervical Cancer Screening Program.

Return to footnote50 referrer

Footnote 51

Quality Management Working Group - Cervical Cancer Prevention Network. Programmatic guidelines for screening for cancer of the cervix in Canada. Ottawa: Society of Gynecologic Oncologists of Canada, 1998.

Return to footnote51 referrer

Footnote 52

Tamblay JL, Catlin G. Sample design of the National Population Health Survey. Health Reports 1995;7:29-38.

Return to footnote52 referrer

Footnote 53

Swain L, Catlin G, Beaudet MP. The National Population Health Survey - its longitudinal nature. Health Rep 1999;10(4):69-82.

Return to footnote53 referrer

Footnote 54

Band PR, Gaudette LA, Hill GB et al. The making of the Canadian Cancer Registry: cancer incidence in Canada and its regions, 1969 to 1988. Health and Welfare Canada, Canadian Council of Cancer Registries, Statistics Canada. Ottawa: Minister of Supply and Services Canada, 1993.

Return to footnote54 referrer

Footnote 55

Gaudette LA, Lee J. Cancer incidence in Canada, 1969-1993. Statistics Canada cat. no. 82-566-XPB edition. Ottawa: Minister of Industry, 1997.

Return to footnote55 referrer

Footnote 56

King HS, Wigle DT, Hill GB, Silins J. Uterine cancers in Alberta: trends of incidence and mortality. Can Med Assoc J 1982;127:591-94.

Return to footnote56 referrer

Footnote 57

Snider JA, Beauvais JE. Pap smear utilization in Canada: estimates after adjusting the eligible population for hysterectomy status. Chron Dis Can 1998;19:19-24.

Return to footnote57 referrer

Footnote 58

Marret LD, Chiarelli AM, Nishri ED, Theis B. Cervical cancer in Ontario 1971-1996. Cancer Care Ontario, Toronto, Canada, 1999.

Return to footnote58 referrer

Cervical Cancer Screening in Canada: 1998 Surveillance Report

Page details

2017-07-31

Language selection

Search

ARCHIVED - Cervical Cancer Screening in Canada: 1998 Surveillance Report

Cervical Cancer Screening in Canada: 1998 Surveillance Report

Page details

ARCHIVED - Cervical Cancer Screening in Canada: 1998 Surveillance Report

We have archived this page and will not be updating it.

We have archived this page and will not be updating it.

Page details